OMB Individually Reported

Real World Data/Evidence

Low riskExact public inventory row

Description

FDA receives numerous submissions containing real-world data and evidence, but identifying and cataloging these studies across various submission types is time-intensive and critical for regulatory reporting requirements under PDUFA (Prescription Drug User Fee Act).

Detailed example

Supports extracting text from unstructured documents and tagging for documents containing Real World Evidence and Real World Data

AI / analytics pattern

Generative AI: AI that generates new or synthetic content (e.g., images, videos, audio, text, code).

Automation level / stage

c) Deployed – The use case is being actively authorized or utilized to support the functions or mission of an agency.

Expected benefit

Assist in identifying industry unstructured submissions containing Real World Data/Evidence (RWD/E) by analyzing parsed content for likely indicators to support congressional reporting and regulatory decision-making.

Controls / human review

ATO: Yes; PIA: Not published

Data needed

applicant submissions